Proteus Digital Health, Inc.   Report issue

For profit Phase 2
Founded: Redwood City CA United States (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2011
NCT01320358
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Proteus Digital Health, Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

escherichia coli nissle 1917 (1 trial)

Drugs in Other Trials (2)

sitagliptin (januvia) (1 trial)

sufonylurea (1 trial)

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3